# Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma

> **NCT01219751** · PHASE2 · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 35 (estimated)

## Conditions studied

- Metastatic Renal Cell Carcinoma

## Interventions

- **DRUG:** Sunitinib

## Key facts

- **NCT ID:** NCT01219751
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-06
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2011-06-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01219751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01219751, "Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01219751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*